DavidCollierMD

PubMed

• 102 citations
  Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
  Dinesh Khanna, Philip J. Clements, Daniel E. Furst, Joseph H. Korn, Michael H. Ellman
  Arthritis and Rheumatism. 2009-04-01
• 1576 citations
  2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
  Frank H J van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron
  Annals of the Rheumatic Diseases. 2013-11-01
• 1771 citations
  2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative
  Frank H J van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron
  Arthritis and Rheumatism. 2013-11-01

Journal Articles

• Anticardiolipin antibodies in scleroderma.  
  Enzenauer RJ, Collier DH, Lopez LR, Journal of Clinical Rheumatology 12: 324-326
• Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon.  
  Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsgar TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jim..., Arthritis Rheum 46(9):2410-2420
• Scleroderma-associated pulmonary hypertension: who’s at risk and why.  
  Fagan KA, Collier DH, Badesch DB, Advances in Pulmonary Hypertension 1(2):5-9
• Predictions and outcomes in scleroderma renal crisis. The high-dose versus low-does D-Penicillamine in early diffuse systemic sclerosis trial.  
  DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WW, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein..., Arthritis Rheum 46(11):2983-2989
• Scleroderma and pulmonary hypertension - Esclerodermia e hipertensâ pulmonar.  
  Fagan KA, Collier DH, Badesch DB, Rev Bras Rheumatol 43(5):294-301
• High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.  
  Clement PJ, Seibold JR, Furst DE, Mayes M, White B, Wigley F, Weisman MD, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier DH, Weinstein A, Lally E, Varga J..., Semin Arthritis Rheum 33:249-263
• The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concern over the use of total-body irradiation in systemic sclerosis.  
  Burt RK, Kallunian K, Patel D, Thomas J, Yeager A, Traynor A, Heipe F, Arnold R, Marmont A, Collier D, Glatstein E, Snowden J, Bone Marrow Transplant 34:745-751
• Responsiveness of the SF-36 and health assessment questionnaire disability index (HAQ-DI) in a systemic sclerosis clinical trial.  
  Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FW, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier D,..., J Rheumatol 32:832-40
• Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases. The evolution from myeloablative to lymphoablative transpl...  
  Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, Fassas A, Snowden F, Schuening F, Myint H, Patel DD, Collier D, Heslop H, Krance R, Statkute L, Verde L, Tray..., Arthritis Rheum 54: 3750-3760
• Fibromyalgia: diagnosis and treatment.  
  Ferucci E, Collier DH, Primary Care Case Reviews 5:101-108
• Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Relaxin in the Treatment of Systemic Sclerosis with Diffuse Scleroderma.  
  Khanna D, Clements PJ, Furst DE, Korn JH, Ellman M, Rothfield N, Wigley FM, Moreland LW, Silver R, Kim YH, Steen VD, Firestein G, Kavanaugh AF, Weisman M, Mayes MD, Co..., Arthritis Rheum;60(4):1102-11
• MQX-503, A Novel Formulation of Nitroglycerin, Improves Severity of Raynaud’s Phenomenon: A Randomized, Controlled Trial.  
  Rothfield N, Shapiro L, Fiorentino D, Chung L, Denton C, Herrick A, Baron M, Shanahan J, Hsu V, Belch J, Steen V, Scheja A, Martin R, Smith E, Mayes M, Simms R, Pope J..., Arthritis Rheum;60(3):870-7
• Health Literacy Predicts the Discrepancy Between Patient and Provider Global Assessments of Rheumatoid Arthritis Activity at a Public Urban Rheumatology Clinic.  
  Hirsh JM, Boyle DJ, Collier DH, Oxenfeld AJ, Caplan L, J Rheumatol;37:961-6
• Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension.  
  Risbano MG, Meadows CA, Coldren CD, Jenkins TJ, Edwards MG, Collier D, Huber W, Mack DG, Fontenot AP, Geraci MW, Bull TM, Clin Trans Sci; 3:210-8
• Increased Expression of Growth Differentiation Factor-15 in Scleroderma –associated pulmonary arterial hypertension.  
  Meadows CA, Risbano MG, Zhang L, Geraci MW, Tuder RM, Collier DH, Bull TM, Chest 2010 Spe 9 (Epub ahead of print)
• Limited health literacy is a common finding in a public health hospital’s rheumatology clinic and is predictive of disease severity.  
  Hirsh JM, Boyle D, Collier D, Oxenfeld A, Nash A, Quinzanos I, Caplan L, Journal of Clinical Rheumatology; 17(5):236-41
• Items for developing revised classification criteria in systemic sclerosis: results of a consensus exercise with the EULAR/ACR working committee.  
  Fransen J, Johnson S, van de Hoogen F, Baron M, Allanore Y, Denton C, Furst D, Czirjak L, Distler O, Gabrielli A, Herrick A, Inanc M, Kahaleh BM, Kowal-Bielecka O, Med..., Arthritis Care Res
• Oral Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study.  
  Wigley FM, Korn JH, Csuka ME, Medsger TA, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Menkel PA, Gruber B, Kaufman L, Va..., Arthritis Rheum 41(4):670-677
• Hypothesis: The nervous system may contribute to the pathogenesis of rheumatoid arthritis.  
  Levine JD, Collier DH, Basbaum AI, Moskowitz MA, Helms CA, J Rheumatol 12(3):406-411
• mmunoglobulin G heavy-chain (Gm) allotypes and the immune response to types I and II collagen in rheumatoid arthritis.  
  Collier DH, Schanfield MS, Kerwar SS, Stobo JD, Disease Markers 3(2):91-102
• Hypertrophic osteoarthropathy associated with achalasia.  
  Collier DH, Zulman JI, Am J Med 81(2):355-362
• Diet and arthritis.  
  Collier DH, Consultant 29(5):63-78
• Skin thickness score in systemic sclerosis (SSc): an assessment of interobserver variability in three independent studies.  
  Clements PJ, Lachenbruch PA, Siebold JR, Zee B, Steen VD, Brennan P, Silman A, Allegar N, Varga J, Massa M, Wigley FM, Ingenito F, Weisman M, Needleman B, Martin RW, M..., J Rheumatol 20:1892-1896
• Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.  
  Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D, Wigley F, Medsger T, Steen V, Moreland L, Dixon M, Massa..., J Rheumatol 22:1281-1285
• Scleroderma: cholesterol crystals and delayed wound healing.  
  Wolf T, Eckhoff D, Collier D, Journal of Orthopaedic Rheumatology 9:60-63
• Join now to see all

Books/Book Chapters

• Medicine: Diagnosis and Treatment. 
  Chapter: Rheumatology and immunology 
  Page 399 - 445Collier DH, Steigerwald JCEditors: Schrier RW.Little, Brown and Co, Boston
• Clinical Internal Medicine in the Aged. 
  Chapter: Musculoskeletal diseases in the elderly 
  Arend WP, Harmon CE, Collier DHEditors: WB Saunders.Schrier RW, PhiladelphiaEdition 2,
• Primary Care Secrets. 
  Chapter: Monoarticular arthritis 
  Page 273 - 276Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, Philadelphia
• Rheumatology Secrets. 
  Chapter: Systemic sclerosis 
  Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Rheumatology Secrets. 
  Chapter: Reflex sympathetic dystrophy syndrome 
  Page 382 - 388Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Rheumatology Secrets. 
  Chapter: Nonsteroidal anti-inflammatory drugs 
  Page 465 - 472Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Geriatric Medicine. 
  Chapter: Musculoskeletal diseases 
  Collier DH, Arend WPEditors: Jahnigen D, Schrier RW.Blackwell Science, CambridgeEdition 2,
• Primary Care Secrets. 
  Chapter: Monarticular arthritis 
  Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, PhiladelphiaEdition 2,
• Primary Care Secrets. 
  Chapter: Polyarticular arthritis 
  Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, PhiladelphiaEdition 2,
• Rheumatology Secrets. 
  Chapter: Systemic sclerosis 
  Page 151 - 160Collier DHEditors: West SG.Hanley & Belfus, Inc, PhiladelphiaEdition 2,
• Rheumatology Secrets. 
  Chapter: Complex regional pain syndrome (reflex sympathetic dystrophy syndrome) 
  Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Rheumatology Secrets. 
  Chapter: Nonsteroidal anti-inflammatory drugs (NSAIDs) 
  Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Primary Care Case. 
  Chapter: romyalgia: diagnosis and treatment 
  Ferucci E, Collier DH
• Advances in Pulmonary Hypertension. 
  Chapter: Scleroderma-associated pulmonary hypertension: who’s at risk and why 
  Fagan KA, Collier DH, Badesch DB
• Primary Care Secrets. 
  Chapter: Monarticular arthritis 
  Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, PhiladelphiaEdition 3,
• Primary Care Secrets. 
  Chapter: Polyarticular arthritis 
  Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, PhiladelphiaEdition 3,
• Join now to see all

Abstracts/Posters

• Clinical utility of serum hyaluronic acid levels in liver disease.
  Santos M, Kondo T, Wieczorek A, Collier D, Lopez L, Clinical Chemistry 41:S71
• Factors Associated with Relapse of Remission in Rheumatoid Arthritis.
  Harrold LR, Reed G, Collier DH, Park GS, Chang H, Koenig AS, Saunders KC, Zack DJ, Kremer JM, Greenberg JD, Arthritis Rheum 63:S122
• Health Literacy Predicts the Discrepancy Between Patient and Provider Global Assessments of Rheumatoid Arthritis Activity at a Public Urban Rheumatology Clinic.
  Hirsh JM, Boyle DJ, Collier DH, Oxenfeld A, Collier A, Cohen A, Caplan L, Arthritis Rheum 60:S369
• Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud’s phenomenon.
  Rothfield N, Shapiro L, Fiorentino D, Chung L, Denton C, Herrick A, Baron M, Shanahan J, Hsu V, Belch J, Steen V, Scheja A, Martin R, Smith E, Mayes M, Simms R, Pope J..., Arhtirits Rheum 58:S821
• Gastric antral vascular ectasia (GAVE) in patients with systemic sclerosis (SSc): a systematic review of the literature.
  Davis L, Collier D, Caplan L, Arthritis Rheum 56:S484
• MQX-503, a movel topical nitroglycerin formulation, improves severity of Raynaud phenomenon in a heterogeneous patient population.
  Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, Hsu V, Rothfield N, Steen V, Martin R, Smith E, Mayes M, Simms R, Pope J, Kahaleh B, Csuka ME, Gruber B,..., Arthritis Rheum 56:S825
• A multi-center placebo-controlled “in-life” study of MQX-503 in patients with Raynaud’s phenomenon.
  Chung L, Baron M, Collier D, Csuka ME, Fiorentino D, Gruber B, Hsu V, Kahaleh B, Martin R, Mayes M, Pope J, Rothfield N, Shanahan J, Shapiro L, Simms R, Smith E, Stee..., Arthritis Rheum 56:S824
• Safety and Tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud’s phenomenon.
  Sule SD, Hummers L, Shapiro L, Fiorentino D, Chung L, Baron M, Shanahan J, Hsu V, Rothfield N, Steen V, Martin R, Dugawson C, Smith E, Mayes M, Simms R, Pope J, Kaha..., Arthritis Rheum 56:S62
• Diaphragmatic dysfunction is a cause of dyspnea and restrictive pulmonary physiology in patients with systemic sclerosis (SSc).
  Hirsh J, Collier D, Brown K, Arthritis Rheum 44:S132
• US phase III trial of relaxin in diffuse scleroderma.
  Seibold JR, Clements PJ, Korn JH, Ellman M, Rothfield NF, Wigley Fm, Moreland LW, Kim Y, Silver RM, Furst DE, Steen VD, Firestein GS, Kavanaugh AF, Mayes MD, Collier D..., J Rheumatol 28 (S63):55
• High-dose (HI-DPA) vs low dose (LO-DPA) penicillamine in early diffuse systemic sclerosis (SSc) trial: Analysis of trial.
  Clements PJ, Wong WK, Seibold JR, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Weinstein A, Medsger T, Steen U, Martin R, Moreland L, Collier D, Lally E, V..., Arthritis Rheum 40:S173
• Controlled trial of recombinant human relaxin (rhRlxn) in diffuse scleroderma (DS).
  Seibold JR, Korn J, Simms R, Clements PJ, Moreland L, Mayes MD, Furst DE, Rothfield N, Steen U, Weisman M, DeMarco P, Collier D, Wigley F, Merkel PA, Csuka ME, Rocco S..., Arthritis Rheum 40:S123
• Acute hemodynamic response to IV Iloprost or prostacycline (PGI2) in patients with pulmonary hypertension associated with systemic sclerosis and other collagen vascula...
  Heller JM, Spencer RT, Collier DH, Badesch DB, Groves BM, Arthritis Rheum 39:S151
• Protein C, protein S, and free protein S levels in patients with liver disease measured by ELISA.
  Butler M, Santos M, Collier D, Lopez L, Clinical Chemistry 41:S170
• Abnormal lymphocyte proliferation in Sjögren's syndrome: Evidence for a lymphocyte subpopula¬tion abnormality and association with HLA B8.
  Michalski JP, McComb C, Fye KH, Talal N, Collier DH, Teraski PI, Arthritis Rheum 19(4):811-12
• Pulmonary hypertension in systemic sclerosis: identification by doppler echocardiogram and clinical features.
  Spencer RT, Turkevich, D, Groves BM, Collier DH, Arthritis Rheum 36:S132
• Neutrophil influx and retention in the lung in systemic sclerosis: a scintographic study.
  Mortenson RL, King TE, Young SK, Ikle D, Collier D, Worthen GS, Am Rev Respir Dis 147:A490
• IgA anticardiolipin antibody associated with interstitial lung disease in systemic sclerosis.
  Collier DH, Enzenauer RJ, Santos M, West S, Lopez L, Arthritis Rheum 35:S346
• Prevalence of antibodies to cardiolipin in rheumatic diseases detected by a standardized enzyme immunoassay.
  Lopez LR, Peterson MJ, Sauer NK, Hites MJ, Collier DH, Enzenauer RJ, Clin Exp Rheum 8:215
• Autonomic nervous system dysfunction in patients with scleroderma.
  Cain WJ, Cohen JA, Collier DH, Clinical Research 38:111A
• Autonomic nervous system (ANS) dysfunction in scleroderma.
  Collier DH, O'Rourke BH, Cohen JA, Arthritis Rheum 32:S35
• Ipsilateral shoulder pain (SP) in carpal tunnel syndrome (CTS).
  Becker JR, Cohen JA, Collier DH, Arthritis Rheum 31(Sup):R25
• Significantly abnormal anti-double stranded DNA (anti-DNA) levels have seasonal variation.
  Collier DH, Levin MJ, Arthritis Rheum 30:S87
• The neuro¬peptide substance P (SP) causes shape change and adhesion in human polymor¬phonuclear leukocytes (PMN).
  Collier DH, Achten MI, Henson J, Henson P, Arend WP, Arthritis Rheum 29(1):S26
• Immunoglobulin G heavy-chain (Gm) allotypes and the immune response to collagen in rheumatoid arthritis (RA).
  Collier DH, Kerwar SS, Stobo JD, Schanfield MS, Clinical Research 33(1):98A
• Join now to see all

Lectures

• Multivariate analysis of spinal and peripheral mineral loss in patients with rheumatoid arthritis. 
  Pan-American Congress of Rheumatology, Washington, D. C
• Class II antigen MT3 association with rheumatoid arthritis. 
  Eleventh ARA Western Regional Meeting, Monterey, California
• The association between collagen antibodies and human Ia molecules. 
  Forty-Seventh Annual Scientific Meeting of the American Rheumatism Association, San Antonio, Texas
• The role of the peripheral nervous system in experimental arthritis. 
  Forty-Eighth Annual Scientific Meeting of the American Rheumatism Association, Minneapolis, Minnesot
• The neuropeptide substance P causes shape change and adhesion in human polymorphonuclear leukocytes. 
  Fourteenth ARA Western Regional Meeting, Oakland, California
• Significantly abnormal anti-double stranded DNA (anti-DNA) levels have seasonal variation. 
  Fifty-First Annual Scientific Meeting of the American Rheumatism Associa¬tion, Washington, D. C
• Significantly abnormal anti-double stranded DNA (anti-DNA) levels have seasonal variation. 
  Seventh Annual Epidemiological Research Exchange, University of Colorado School of Medicine
• Ipsilateral shoulder pain in carpal tunnel syndrome. 
  Fifty-Second Annual Scientific Meeting of the American Rheumatism Association, Houston, Texas
• Autonomic nervous system dysfunction in scleroderma. 
  Fifty-Third Annual Scientific Meeting of the American College of Rheumatol¬ogy, Cincinnati, Ohio
• Controlled epidemiologic survey of toxic exposure in patients with systemic sclerosis. 
  Tenth Annual Epidemiological Research Exchange, University of Colorado School of Medicine, Denver
• IgA anticardiolipin antibody associated with interstitial lung disease in systemic sclerosis. 
  Fifth International Symposium on Antiphospholipid Antibodies, San Antonio, Texas
• The role of the neuropeptide substance P in experimental arthritis. 
  Arizona State University, Tempe, Arizona
• Reflex sympathetic dystrophy. 
  William Beaumont Army Medical Center, El Paso, Texas
• Pathophysiologic approach to reflex sympathetic dystrophy. 
  Eleventh Annual Rheumatology on the Beach, Destin, Florida
• Review of clinical rheumatology, laboratory tests in rheumatology, and therapeutic management in the United States. 
  Bach Mai Hospital, Hanoi, Vietnam
• Complex regional pain syndrome (reflex sympathetic dystrophy). 
  Mississippi Pain Society, Jackson, Mississippi
• ACR/ARHP Combined Clinical Symposium: Practical management of common hand problems, with Pamela B. Harrell, OTR, CHT. 
  1998 ACR/ARHP National Scientific Meeting, San Diego, California
• Non-operative and medical management of osteoarthritis. 
  University of Arizona,Phoenix, Arizona
• New treatments in the management of osteoarthritis. 
  Rocky Mountain Rheumatism Society, Denver, Colorado
• Non-Operative and medical management of osteoarthritis. 
  University of Arizona, St. Joseph’s Hospital and the Institute for Bone and Joint Disorder sponsored
• Scleroderma from a rheumatologist’s perspective. 
  Medicis Winter Skin Seminar, Snowmass, CO
• Radiology of common rheumatic diseases. 
  Seventh Annual Rheumatology and Musculoskeletal Disease Conference, Rose Medical Center
• Soft tissue rheumatism. 
  University of Colorado School of Medicine, YMCA Conference Center, Estes Park, Colorado
• Septic arthritis, crystal-induced arthritis, and seronegative spondyloarthropathies. 
  Fourth Annual Internal Medicine Board Review Course, University of Colorado School of Medicine
• Treatment of rheumatoid arthritis. 
  Thirty-Third Annual Family Practice Review, University of Colorado School of Medicine, Denver
• Join now to see all